← Evidence map

ArticleNeurology2026

Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis.

Annette Langer-Gould et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41428985